- Home
- Johnson & Johnson
Johnson & Johnson
The 5 stages of COVID-19 vaccine development: What you need to know about how a clinical trial works
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
6 top questions about COVID-19: What a school nurse has to say
On the next episode of The Road to a Vaccine, host Lisa Ling delves into how the pandemic is affecting parents, children and school staff. We sat down with one of the upcoming guests, school nurse Robin Cogan, to find out the most pressing questions on her mind—and those of moms and dads.
Cancer scientist Lewis Cantley, Ph.D., wins the 2020 Dr. Paul Janssen Award for biomedical research
Cancer. Diabetes. Autoimmune diseases. They’re the common illnesses we have a better chance at fighting, thanks to Dr. Cantley’s pioneering work. Learn more about his “magic molecule” research.
4 high-tech tools Johnson & Johnson is using to get products to you during the pandemic
Smart glasses with remote access capabilities. Track-and-trace sensors powered by GPS. These are just two cutting-edge technologies the company has tapped to help keep its supply chain running smoothly at manufacturing and shipping facilities around the world.
Johnson & Johnson Consumer Health commits $800 million through 2030 to make its products more sustainable for a healthier planet
As part of its new Healthy Lives Mission, the company’s iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.
Johnson & Johnson signs a historic pledge to uphold the integrity of the scientific process in developing an investigational COVID-19 vaccine
In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.
4 innovative ways Johnson & Johnson has helped protect the public’s health during outbreaks since the late 1800s
From epidemic masks that the company introduced during the Spanish flu pandemic to work it’s doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.
Johnson & Johnson named to Fast Company‘s 2020 Best Workplaces for Innovators list
The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company’s culture.
5 questions for a scientist who’s working to uncover new treatments for psoriatic arthritis
Early in his career Daniel Cua, Ph.D., made a discovery that would lead to a new medication for the debilitating autoimmune disease. We sat down with Dr. Cua, known as “the father” in his field of study, to learn what his work could mean for those with psoriatic arthritis.
Johnson & Johnson earns the #3 spot on the 2020 Gartner Supply Chain Top 25 list
The company received its highest-ever ranking on the list this year—which honors global supply chain excellence—in part for its nimble response to the COVID-19 pandemic.